Zimmer Biomet Holdings Accounts Payable increased by 19.2% to $361.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.9%, from $301.30M to $361.20M. Over 5 years (FY 2020 to FY 2025), Accounts Payable shows relatively stable performance with a -1.7% CAGR.
An increase can signal improved cash management or extended payment terms, while a decrease may indicate faster payments to suppliers or reduced purchasing activity.
This represents the short-term obligations owed to suppliers and vendors for goods and services received on credit. It i...
Standard current liability for all companies; comparable across industries based on days payable outstanding.
accounts_payable| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $360.60M | $327.60M | $306.50M | $322.00M | $307.10M | $333.90M | $354.10M | $397.10M | $354.60M | $319.70M | $410.60M | $370.30M | $341.80M | $322.40M | $194.60M | $301.30M | $348.70M | $315.30M | $303.00M | $361.20M |
| QoQ Change | — | -9.2% | -6.4% | +5.1% | -4.6% | +8.7% | +6.0% | +12.1% | -10.7% | -9.8% | +28.4% | -9.8% | -7.7% | -5.7% | -39.6% | +54.8% | +15.7% | -9.6% | -3.9% | +19.2% |
| YoY Change | — | — | — | — | -14.8% | +1.9% | +15.5% | +23.3% | +15.5% | -4.3% | +16.0% | -6.7% | -3.6% | +0.8% | -52.6% | -18.6% | +2.0% | -2.2% | +55.7% | +19.9% |